Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2007
03/13/2007US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
03/13/2007US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
03/13/2007US7189534 PRO4320 polynucleotide
03/13/2007US7189533 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189532 PRO polypeptides; fusion proteins
03/13/2007US7189531 Nucleotide sequences coding polypeptide for use in the transport of carbohydrates throughout plant cells
03/13/2007US7189530 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders
03/13/2007US7189529 PRO792 nucleic acids
03/13/2007US7189525 Human enzymes of the metalloprotease family
03/13/2007US7189521 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/13/2007US7189517 Goodpasture antigen binding protein
03/13/2007US7189515 Human antibodies as detection reagents
03/13/2007US7189514 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof
03/13/2007US7189510 Response element compositions and assays employing same
03/13/2007US7189505 Methods of assessing HIV integrase inhibitor therapy
03/13/2007US7189404 Strain selection of pneumococcal surface proteins
03/13/2007US7189401 Modified viral geomes for use in vectors or vaccines. Replication of DNA or DNA polymerase
03/13/2007US7189398 Amino acid sequence substantially homologous to the amino acid sequence of a fragment of a pyrogenic exotoxin, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin
03/13/2007US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes
03/13/2007CA2419461C Microorganisms and assays for the identification of antibiotics
03/13/2007CA2394609C Conformational and topological protein regulation
03/13/2007CA2311641C Pseudo-type retroviral vectors with modifiable surface capsid proteins
03/13/2007CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use
03/13/2007CA2262531C Assessment of cervical cells
03/13/2007CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna
03/13/2007CA2240494C Therapeutic molecules generated by trans-splicing
03/13/2007CA2235398C Expression system in microorganism and its use for expressing heterologous and homologous proteins
03/13/2007CA2215763C Transformed embryogenic microspores for the generation of fertile homozygous plants
03/13/2007CA2203815C Enhanced carotenoid accumulation in storage organs of genetically engineered plants
03/13/2007CA2170604C Nucleic acid purification compositions and methods
03/13/2007CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/13/2007CA2161387C Rapid and efficient regeneration of transgenic plants
03/13/2007CA2160922C Hiv immunogenic complexes
03/13/2007CA2101463C Recombinant adenovirus vaccines
03/13/2007CA2099482C Anther-specific cdna sequences, genomic dna sequences and recombinant dna sequences
03/13/2007CA2063890C Mutant aox2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism
03/13/2007CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives
03/12/2007CA2561992A1 Polynucleotides and uses thereof
03/08/2007WO2007028165A2 Stress tolerance in plants
03/08/2007WO2007028121A2 Eg8798 and eg9703 polynucleotides and uses thereof
03/08/2007WO2007028084A2 Method and molecular diagnostic device for detection, analysis and identification of genomic dna
03/08/2007WO2007027954A2 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
03/08/2007WO2007027947A2 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport
03/08/2007WO2007027894A2 Antisense compounds having enhanced anti-microrna activity
03/08/2007WO2007027860A2 Adenoviral vector-based malaria vaccines
03/08/2007WO2007027776A2 Insecticidal compositions and methods for making insect-resistant transgenic plants
03/08/2007WO2007027775A2 Methods for use in modulating mir-122a
03/08/2007WO2007027774A1 Targeting of herpes simplex virus to specific receptors
03/08/2007WO2007027718A1 Methods of altering an immune response induced by cpg oligodeoxynucleotides
03/08/2007WO2007027714A2 Engineered anti-il-23 antibodies
03/08/2007WO2007027713A2 Trail receptor 2 polypeptides and antibodies
03/08/2007WO2007027559A2 Neuroprotective and neurorestorative methods and compositions
03/08/2007WO2007027106A1 Dual-fluorescent reporter construct and assay for measuring translational recoding
03/08/2007WO2007026992A1 Sirna having antiviral activity against nonpolio enterovirus
03/08/2007WO2007026973A1 Recombinant adeno-associated virus containing vegfr truncated cdna and gene therapeutic agent for cancer comprising the same
03/08/2007WO2007026958A1 Tryptophan transporter gene and use thereof
03/08/2007WO2007026956A1 Gene capable of enhancing low temperature fermentation ability and/or freezing stress resistance and use thereof
03/08/2007WO2007026940A1 Method for detection of gene polymorphism and method for screening of substance
03/08/2007WO2007026929A1 Method for separating and purifying rna
03/08/2007WO2007026926A1 NOVEL 16S rRNA METHYLASE GENE, PROTEIN PRODUCED FROM THE GENE, AND METHOD FOR DETECTION OF THE GENE OR PROTEIN
03/08/2007WO2007026896A1 Composition and method for diagnosing kidney cancer and estimating kidney cancer patient’s prognosis
03/08/2007WO2007026895A1 Kit and method for detection of urothelial cancer
03/08/2007WO2007026874A1 Method for screening of substance effective on disease using gpr120 and phospholipase
03/08/2007WO2007026823A1 Detection of target nucleic acid based on the formation of triplex nucleic acid using artificial nucleic acid probe
03/08/2007WO2007026807A1 Improvement of eukaryotic cell-free protein synthesis system
03/08/2007WO2007026772A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof
03/08/2007WO2007026705A1 Method of constructing gene expression image and system for constructing gene expression image
03/08/2007WO2007026698A1 Gene causative of the aging smell of malt drink and utilization of the same
03/08/2007WO2007026661A1 Method for specifically selecting antibody-producing cell
03/08/2007WO2007026617A1 Expression vector, transformant having the expression vector introduced therein, and process for production of heterologous protein
03/08/2007WO2007026595A1 Universal base-containing polymer
03/08/2007WO2007026516A1 Novel drug delivery system
03/08/2007WO2007026485A1 Universal base
03/08/2007WO2007026310A2 Improved stress tolerance in plants
03/08/2007WO2007026173A1 Transgenic animal model for identifying modulators of protein kinase
03/08/2007WO2007026146A1 Treatment using herpes simplex virus
03/08/2007WO2007026120A2 Preprotachykinin enhancer elements
03/08/2007WO2007026049A2 Improved method for fermentation by repairing yeast genes
03/08/2007WO2007026009A1 Novel tyrosinase-specific antigenic oligonucleotides as depigmenting agents
03/08/2007WO2007025977A2 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
03/08/2007WO2007025719A1 Modified spider silk proteins
03/08/2007WO2007025554A1 Method for the generation of antigen-specific t-cells and uses thereof
03/08/2007WO2007025431A1 Recombinant newcastle disease lasota attenuated vaccine strain expressing vp2 gene of infectious bursal disease virus
03/08/2007WO2007025420A1 Low virulent strain of recombinant newcastle disease lasota vaccine expressing ha protein of avian influenza-h5 virus
03/08/2007WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
03/08/2007WO2007025388A2 Anti-apoptotic protein antibodies
03/08/2007WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
03/08/2007WO2007025333A1 Bacterial delivery of biologically active polypeptides
03/08/2007WO2006137941A9 Methods and compositions involving mirna and mirna inhibitor molecules
03/08/2007WO2006136697A3 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
03/08/2007WO2006136383A8 Selection of phosphatase-coding nucleic acid molecules
03/08/2007WO2006131936A3 Hepatitis c virus vaccine
03/08/2007WO2006127585A3 Transduction of primary cells
03/08/2007WO2006125756A3 Nucleic acid molecules encoding echi-like polypeptides and methods of use
03/08/2007WO2006124686A3 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
03/08/2007WO2006122050A3 Methods and compositions for detecting immune responses
03/08/2007WO2006119987A3 Recombinant n-glycosylated proteins from procaryotic cells
03/08/2007WO2006119365A3 Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster
03/08/2007WO2006110760A3 Compositions and methods for the diagnosis and treatment of tumor
03/08/2007WO2006102491A3 Alteration of plant embryo/endosperm size during seed development